110 related articles for article (PubMed ID: 6338603)
1. Indoramin as an antihypertensive agent in the treatment of essential hypertension. A multicentre trial.
Bednarek MR; Schoeman HS
S Afr Med J; 1983 Mar; 63(11):398-400. PubMed ID: 6338603
[TBL] [Abstract][Full Text] [Related]
2. Indoramin as second step therapy in the management of benign essential hypertension.
Montenero AS; Mazzari M; Schiavoni G; Manzoli U; Gherardi S
Pharmatherapeutica; 1983; 3(6):417-21. PubMed ID: 6353433
[TBL] [Abstract][Full Text] [Related]
3. Double-blind study comparing indoramin and propranolol in the treatment of black patients with hypertension.
Bennett JM; Weich DJ; Schoeman HS
S Afr Med J; 1988 Dec; 74(12):619-21. PubMed ID: 3061032
[TBL] [Abstract][Full Text] [Related]
4. [Open study on the effect and side effects of indoramin, used at the 2d and 3d therapeutic step in essential hypertension].
Hitzenberger G; Korn A
Wien Med Wochenschr; 1985 Sep; 135(17):425-30. PubMed ID: 4060742
[TBL] [Abstract][Full Text] [Related]
5. Indoramin in the treatment of hypertension. A mini-review and update.
Archibald JL; Turner P
S Afr Med J; 1983 Feb; 63(9):307-9. PubMed ID: 6338605
[TBL] [Abstract][Full Text] [Related]
6. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
[TBL] [Abstract][Full Text] [Related]
8. Indoramin in the treatment of hypertension: a placebo controlled trial.
Ramirez J
Curr Med Res Opin; 1976; 4(3):177-84. PubMed ID: 780059
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effect of indoramin and prazosin on blood pressure and lipid profiles in essential hypertension.
Overlack A; Stumpe KO
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S53-5. PubMed ID: 2423798
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive therapy with indoramin in the elderly.
Deitch MW; Allen IE; Pascucci VL
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S88-92. PubMed ID: 2423807
[TBL] [Abstract][Full Text] [Related]
11. Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.
Holmes B; Sorkin EM
Drugs; 1986 Jun; 31(6):467-99. PubMed ID: 3525084
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive therapy with indoramin: risk-benefit profile in clinical practice.
Stannard M; Cohen M; Marrott PK; Pascucci VL
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S48-52. PubMed ID: 2423797
[TBL] [Abstract][Full Text] [Related]
13. Comparison of indoramin and methyldopa in hypertension.
Rosendorff C
S Afr Med J; 1976 May; 50(20):764-8. PubMed ID: 779054
[TBL] [Abstract][Full Text] [Related]
14. Oxprenolol and a thiazide diuretic together in the treatment of essential hypertension--a large general practice study.
Forrest WA
Br J Clin Pract; 1973 Sep; 27(9):331-5. PubMed ID: 4595072
[No Abstract] [Full Text] [Related]
15. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive therapy in the Federal Republic of Germany: clinical practice experience with indoramin (Wydora).
Grube E; Giesing M
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S43-7. PubMed ID: 2423796
[TBL] [Abstract][Full Text] [Related]
17. [Spironolactone-thiazides-reserpine. Antihypertensive effect in essential arterial hypertension].
de los Rios JC; OrtÃz Feijoo J; Otero Cagide F
Prensa Med Mex; 1976; 41(7-8):210-4. PubMed ID: 796845
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
19. [Prazosine: a new vasodilator used for treatment of hypertension (author's transl)].
Godin M; Fillastre JP; Bret M
Nouv Presse Med; 1978 Dec; 7(45):4139-41. PubMed ID: 370766
[TBL] [Abstract][Full Text] [Related]
20. Effect of thiazide-based therapy on serum alkaline phosphatase. Hypertension Detection and Follow-up Group.
Langford HG; Curb JD; Pressel S; Schneider KA
J Hum Hypertens; 1991 Aug; 5(4):333-8. PubMed ID: 1956030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
